0000000000200014

AUTHOR

Filippo M. Sarullo

0000-0003-2046-8316

showing 30 related works from this author

Normal-sodium diet compared with low-sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend?

2007

The aim of the present study was to evaluate the effects of a normal-sodium (120 mmol sodium) diet compared with a low-sodium diet (80 mmol sodium) on readmissions for CHF (congestive heart failure) during 180 days of follow-up in compensated patients with CHF. A total of 232 compensated CHF patients (88 female and 144 male; New York Heart Association class II–IV; 55–83 years of age, ejection fraction <35% and serum creatinine <2 mg/dl) were randomized into two groups: group 1 contained 118 patients (45 females and 73 males) receiving a normal-sodium diet plus oral furosemide [250–500 mg, b.i.d. (twice a day)]; and group 2 contained 114 patients (43 females and 71 males) recei…

Malemedicine.medical_specialtyfood.dietLow sodium dietPlasma renin activityGastroenterologyPatient Readmissionchemistry.chemical_compoundfoodFurosemideInternal medicineNatriuretic Peptide BrainReninmedicineHumansDiureticsAldosteroneAgedAged 80 and overHeart FailureEjection fractionAldosteronebusiness.industryFurosemideSodium DietaryGeneral MedicineDiet Sodium-RestrictedMiddle Agedmedicine.diseaseBrain natriuretic peptideCombined Modality TherapySurvival AnalysisEndocrinologyTreatment OutcomechemistryHeart failureFemalebusinessmedicine.drugLow sodiumFollow-Up StudiesClinical science (London, England : 1979)
researchProduct

Heart rate turbulence for guiding electric therapy in patients with cardiac failure

2009

It is well-known that a reduction of the cardiac frequency variability, measurable with the Heart Rate Variability (HRV) system, is an indirect expression of the sympathetic-autonomic tone. Another index, Heart Rate Turbulence (HRT), has been recently suggested as a possible unit of measurement for the sympathetic-autonomic tone: this system allows to estimate the baro-reflex response of the carotid arteries to an early ventricular extra-systole by analysing heart rate variations induced by a premature beat.In our research we have analyzed this phenomenon in patients affected by moderate or severe cardiac failure. In particular, we divided 110 patients into two arms: subjects with or withou…

Malemedicine.medical_specialtyCarotid arteriesElectric CountershockBeat (acoustics)Health Informaticstherapycardiac failureCritical Care and Intensive Care MedicineSensitivity and SpecificitySudden deathHeart rate turbulenceHeart RateInternal medicineHeart ratemedicineHumansHeart rate variabilityIn patientDiagnosis Computer-AssistedHeart Failurebusiness.industryReproducibility of ResultsArrhythmias CardiacElectroencephalographyMiddle AgedAnesthesiology and Pain MedicineTherapy Computer-Assistedcardiovascular systemCardiologyFemaleCardiac frequencybusinessAlgorithmsJournal of Clinical Monitoring and Computing
researchProduct

Effect of physical training on exercise capacity, gas exchange and N-terminal pro-brain natriuretic peptide levels in patients with chronic heart fai…

2006

BACKGROUND: Decreased exercise capacity is the main factor restricting the daily life of patients with chronic heart failure. N-terminal pro-brain natriuretic peptide (NT pro-BNP) is strongly related to the severity of and is an independent predictor of outcome in chronic heart failure. DESIGN: The study aimed to evaluate the effect of exercise training on functional capacity and on changes in NT pro-BNP levels and to assess the effect of exercise training on quality of life. MATERIALS AND METHODS: Sixty patients (45 men/15 women, mean age 52.7 years; +/-5.3 SD), with stable heart failure (45 ischaemic/hypertensive and 15 idiopathic patients), in New York Heart Association (NYHA) functional…

Malemedicine.medical_specialtyEpidemiologymedicine.drug_classInternal medicineNatriuretic Peptide BrainNatriuretic peptideMedicineHumansIn patientExercise physiologycongestive heart failure exercise capacity gas exchange N-terminal pro-brain natriuretic peptide physical trainingExerciseHeart FailureEjection fractionbusiness.industryPulmonary Gas ExchangeExercise capacityMiddle AgedBrain natriuretic peptidemedicine.diseasePeptide FragmentsPhysical FitnessHeart failureCardiologyFemaleCardiology and Cardiovascular MedicinebusinessN-terminal pro-Brain Natriuretic PeptideEuropean journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on EpidemiologyPrevention and Cardiac Rehabilitation and Exercise Physiology
researchProduct

Impact of ''off-label'' use of ivabradine on exercise capacity, gas exchange, functional class, quality of life, and neurohormonal modulation in pati…

2010

Background: Epidemiologic studies indicate that elevated heart rate (HR) is an independent risk factor for mortality and morbidity in patients (pts) with chronic heart failure (CHF). Clinical trials with b-blockers suggest that HR reduction is an important mechanism of their benefit in pts with stable CHF. Pharmacologic inhibition of the If current now provides the opportunity of pure HR reduction. The purpose of this study was to evaluate the impact of ‘‘Off-Label’’ use of ivabradine on exercise capacity, gas exchange, functional class, quality of life, and neurohormonal modulation in pts with ischemic CHF. Methods: Between January 2008 and June 2008, a graded maximal exercise test with re…

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaAdrenergic beta-AntagonistsOff-label uselaw.inventionOxygen ConsumptionQuality of lifeRandomized controlled triallawHeart RateInternal medicinemedicineHumansPharmacology (medical)IvabradineExercise physiologyRisk factorExercisePharmacologyHeart Failureivabradine heart failure exercise capacityNeurotransmitter AgentsExercise Tolerancebusiness.industryOff-Label UseBenzazepinesmedicine.diseaseClinical trialHeart failureChronic DiseaseCardiologyExercise TestQuality of LifeFemaleCardiology and Cardiovascular MedicinebusinessIvabradinemedicine.drugJournal of cardiovascular pharmacology and therapeutics
researchProduct

Changes in plasma lipids and low-density lipoprotein peak particle size during and after acute myocardial infarction

2002

In summary, LDL peak particle size variations occur very early after AMI, and therefore this parameter, which may be considered a genetically determined risk factor, must be measured not before 2 to 3 months after the acute event.

AdultMalemedicine.medical_specialtyMyocardial Infarctionchemistry.chemical_compoundInternal medicineBlood plasmaPlasma lipidsmedicineHumansMyocardial infarctionLow-Density Lipoprotein Acute Myocardial InfarctionRisk factorAgedAged 80 and overbusiness.industryCholesterolCholesterol HDLCholesterol LDLMiddle Agedmedicine.diseaseLipidsCoronary heart diseaseEndocrinologychemistryLow-density lipoproteinCardiologyParticle sizeCardiology and Cardiovascular MedicinebusinessThe American Journal of Cardiology
researchProduct

Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline …

2005

OBJECTIVES: The aim of this study was to evaluate the effect of a new treatment for refractory congestive heart failure (CHF) on brain natriuretic peptide (BNP) plasma levels and hydration station. BACKGROUND: The study was aimed at evaluating the effects of the combination of high-dose furosemide and small-volume hypertonic saline solution (HSS) in refractory CHF patients. METHODS: A total of 94 patients (34 women/60 men) with refractory CHF (age 55 to 80 years) were enrolled. They had to have an ejection fraction <35%, serum creatinine <2 mg/dl, blood urea nitrogen <60 mg/dl, a reduced urinary volume, and a low natriuresis (<500 ml/24 h and <60 mEq/24 h, respectively). Pati…

Malemedicine.medical_specialtyTime Factorsmedicine.drug_classNatriuresisDouble-Blind MethodFurosemideHeart rateNatriuretic Peptide BrainNatriuretic peptidemedicineElectric ImpedanceHumansDiureticsBlood urea nitrogenAgedAged 80 and overHeart FailureSaline Solution HypertonicEjection fractionDose-Response Relationship Drugbusiness.industryBioelectrical ImpedanceBrain Natriuretic peptideFurosemideMiddle Agedmedicine.diseaseBrain natriuretic peptideSurgeryHeart failureAnesthesiaDrug Therapy CombinationFemaleCardiology and Cardiovascular Medicinebusinessmedicine.drugFollow-Up StudiesJournal of the American College of Cardiology
researchProduct

Short-Term Effects of Hypertonic Saline Solution in Acute Heart Failure and Long-Term Effects of a Moderate Sodium Restriction in Patients With Compe…

2011

INTRODUCTION: Hypertonic saline solution (HSS) and a moderate Na restriction plus high furosemide dose showed beneficial effects in compensated heart failure (HF), in short and long terms. The study was aimed to verify the effects of this combination on hospitalization time, readmissions and mortality in patients in New York Heart Association (NYHA) class III. METHOD: Chronic ischemic or nonischemic cardiomyopathy uncompensated patients with HF in NYHA III functional class with ejection fraction <40%, serum creatinine <2.5 mg/dL, blood urea nitrogen <60 mg/dL and reduced urinary volume were single-blind randomized in 2 groups: the first group received a 30-minute intravenous infusion of fur…

Malemedicine.medical_specialtyHeart diseasemedicine.medical_treatmentDiuresisPatient ReadmissionFurosemideInternal medicinemedicineHumansInfusions IntravenousAgedAged 80 and overHeart FailureSaline Solution HypertonicEjection fractionbusiness.industrySodiumFurosemideGeneral MedicineDiet Sodium-RestrictedMiddle Agedmedicine.diseaseHyepertonic saline heart failure diureticsDiuresisSurgeryHospitalizationTreatment OutcomeHeart failureCirculatory systemCardiologyTonicityFemaleDiureticbusinessmedicine.drugThe American Journal of the Medical Sciences
researchProduct

Comparison of Ivabradine Versus Metoprolol in Early Phases of Reperfused Anterior Myocardial Infarction With Impaired Left Ventricular Function: Prel…

2009

BACKGROUND: beta-blockers in ST-segment elevation myocardial infarction (STEMI) are indicated for patients without a contraindication, particularly in patients with high heart rates (HR) or blood pressures. Epidemiological studies have shown that elevated HR represents a risk factor for cardiovascular morbidity. The study investigates the feasibility, tolerability, and the effects after 30 days of follow-up of ivabradine (IVA) versus metoprolol (METO) in early phases of anterior STEMI reperfused by percutaneous coronary intervention (PCI). METHODS AND RESULTS: Patients with a first anterior STEMI, Killip class I-II, an acceptable echocardiographic window, and admitted within 4hours of the o…

Malemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentMyocardial InfarctionMyocardial Reperfusion InjuryPilot ProjectsVentricular Dysfunction LeftDouble-Blind MethodInternal medicineejection fraction end systole volume ivabradinemedicineHumansIvabradinecardiovascular diseasesMyocardial infarctionAgedMetoprololKillip classEjection fractionbusiness.industryPercutaneous coronary interventionBenzazepinesMiddle Agedmedicine.diseasesurgical procedures operativeConventional PCICardiologyMyocardial infarction complicationsFemaleCardiology and Cardiovascular MedicinebusinessIvabradineFollow-Up StudiesMetoprololmedicine.drugJournal of Cardiac Failure
researchProduct

415 Does angiotensin-converting enzyme I/D polymorphism afect blood pressure and diastolic function? Findings after six years of follow up in healthy…

2003

medicine.medical_specialtyBlood pressureAngiotensin converting enzyme ibusiness.industryPolymorphism (computer science)Internal medicinemedicineHealthy subjectsCardiologyDiastolic functionCardiology and Cardiovascular MedicinebusinessEuropean Journal of Heart Failure Supplements
researchProduct

The Effects of Sacubitril/Valsartan on Clinical, Biochemical and Echocardiographic Parameters in Patients with Heart Failure with Reduced Ejection Fr…

2019

Background: Sacubitril/valsartan has been shown to be superior to enalapril in reducing the risks of death and hospitalization for heart failure (HF). However, knowledge of the impact on cardiac performance remains limited. We sought to evaluate the effects of sacubitril/valsartan on clinical, biochemical and echocardiographic parameters in patients with heart failure and reduced ejection fraction (HFrEF). Methods: Sacubitril/valsartan was administered to 205 HFrEF patients. Results: Among 230 patients (mean age 59 &plusmn

medicine.medical_specialtymedicine.medical_treatmentheart failureHemodynamics030204 cardiovascular system & hematologyArticleSacubitril03 medical and health sciences0302 clinical medicinehemodynamicInternal medicinemedicineechocardiography030212 general & internal medicineEnalaprilremodelingEjection fractionbusiness.industryneprilysin inhibitionGeneral Medicinemedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareValsartansacubitril/valsartanHeart failureCardiologyreduced ejection fractionDiureticbusinessNt-ProBNPSacubitril Valsartanmedicine.drugJournal of Clinical Medicine
researchProduct

The old and new tests for celiac disease: which is the best test combination to diagnose celiac disease in pediatric patients?

2011

BACKGROUND In the diagnosis of celiac disease (CD), serum assays for anti-endomysium (EMA) and anti-transglutaminase (anti-tTG) antibodies have excellent diagnostic accuracy. However, these assays are less sensitive in young pediatric patients. Recently, a new ELISA test using deamidated gliadin peptides (DGP) as antigen has proved to be very sensitive and specific even in pediatric patients. In addition, anti-actin IgA antibodies (AAA) is another test that can be used in CD patients because antibody concentrations correlate with the degree of villous atrophy. This study evaluated the clinical accuracy of anti-tTG, EMA, AGA, anti-DGP and AAA and the effectiveness of these in different combi…

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaTissue transglutaminaseClinical BiochemistryFluorescent Antibody TechniqueDiagnostic accuracyEnzyme-Linked Immunosorbent AssayDiseaseGastroenterologySensitivity and SpecificityAntigenInternal medicinemedicineHumansceliac disease; diagnostic test; pediatric patientspediatric patientsbiologybusiness.industryClinical Laboratory TechniquesBiochemistry (medical)InfantGeneral MedicineReference StandardsEndomysiummedicine.anatomical_structurediagnostic testCase-Control StudiesChild PreschoolElisa testbiology.proteinFemaleAntibodyGliadinbusinessceliac disease
researchProduct

Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently…

2008

Studies have shown that patients with compensated heart failure (HF) receiving high diuretic doses associated with normal sodium diet and fluid intake restrictions demonstrated significant reductions in readmissions and mortality compared with those who received low-sodium diets, and over a 6-month observation period, a reduction in neurohormonal activation was also observed. The aim of this study was to evaluate the effects of different sodium diets associated with different diuretic doses and different levels of fluid intake on hospital readmissions and neurohormonal changes after 6-month follow-up in patients with compensated HF. Four hundred ten consecutive patients with compensated HF …

Malemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentchemistry.chemical_compoundElectrocardiographyInternal medicineHeart rateNatriuretic Peptide BrainReninmedicineHumansDiureticsAldosteroneAgedRetrospective StudiesHeart FailureAldosteroneEjection fractionmedicine.diagnostic_testDose-Response Relationship Drugbusiness.industryFurosemideSodium DietaryStroke VolumeDiet Sodium-Restrictedmedicine.diseaseBlood pressureTreatment OutcomechemistryEchocardiographyHeart failureCardiologyFemaleDiureticCardiology and Cardiovascular MedicinebusinessElectrocardiographymedicine.drugFollow-Up StudiesThe American journal of cardiology
researchProduct

Is delayed facilitated percutaneous coronary intervention better than immediate in reperfused myocardial infarction? Six months follow up findings

2006

Background: There are several new strategies proposed to improve the outcome of patients with ST-elevation myocardial infarction (STEMI). One approach is the resurgent use of facilitated percutaneous coronary interventions (PCI). Until recently, deciding whether immediate PCI after combined treatment (facilitated PCI) is more appropriate than delayed PCI (short time) has not been investigated. The aim of this study, therefore, was to investigate the outcomes in patients initially successfully treated pharmacologically and immediate PCI < 2 hr, and in patients initially successfully treated with pharmacological therapy and with delayed PCI (12–72 h). Methods: 451 reperfused STEMI patients, a…

Malemedicine.medical_specialtyTiclopidineTime Factorsmedicine.medical_treatmentMyocardial InfarctionFacilitated Percutaneous Coronary InterventionPlatelet Glycoprotein GPIIb-IIIa ComplexGIIb/IIIa inhibitorDelayed Percutaneous Coronary InterventionsInternal medicineAngioplastymedicineAbciximabAcute myocardial InfarctionHumanscardiovascular diseasesMyocardial infarctionAngioplasty Balloon CoronaryAgedbusiness.industryAnticoagulantsPercutaneous coronary interventionHematologyTirofibanMiddle AgedClopidogrelmedicine.diseaseCombined Modality TherapyClopidogrelsurgical procedures operativeTissue Plasminogen ActivatorConventional PCICardiologyFemaleCardiology and Cardiovascular MedicinebusinesstherapeuticsCombined therapyPlatelet Aggregation InhibitorsTIMIFollow-Up Studiesmedicine.drugJournal of Thrombosis and Thrombolysis
researchProduct

Cardiopulmonary Exercise Testing in Patients with Chronic Heart Failure: Prognostic Comparison from Peak VO2 and VE/VCO2 Slope

2010

Background: Cardiopulmonary exercise testing with ventilatory expired gas analysis (CPET) has proven to be a valuable tool for assessing patients with chronic heart failure (CHF). The maximal oxygen uptake (peak V02) is used in risk stratification of patients with CHF. The minute ventilation-carbon dioxide production relationship (VE/VCO2 slope) has recently demonstrated prognostic significance in patients with CHF. Methods: Between January 2006 and December 2007 we performed CPET in 184 pts (146 M, 38 F, mean age 59.8 ± 12.9 years), with stable CHF (96 coronary artery disease, 88 dilated cardiomyopathy), in NYHA functional class II (n.107) - III (n.77), with left ventricular ejection frac…

Congestive heart failuremedicine.medical_specialtygas exchangeArticleCoronary artery diseaseInternal medicineMedicineEjection fractionReceiver operating characteristicbusiness.industryventilationVO2 maxDilated cardiomyopathyCARDIOPULMONARY CHRONIC HEART FAILUREmedicine.diseaseexercise capacityLog-rank testprognosis.Heart failureBreathingCardiologyPhysical therapyCardiology and Cardiovascular Medicinebusinesshuman activitiescirculatory and respiratory physiologyThe Open Cardiovascular Medicine Journal
researchProduct

Tako-tsubo cardiomyopathy and microcirculation.

2010

Takotsubo cardiomyopathy was described for the first time in Japan in the 1990s. It is very similar to the ischemic cardiopathy both for clinical and instrumental characteristics. His peculiarity is an alteration of the ventricular contraction mechanism with hypo-akinesis of the apex and lateral segments of the left ventricle, associated with hyper-kinesis of the heart base which is responsible for the typical echocardiographic aspect of a cruet during the systole. However, the etiology of this cardiomyopathy is still unknown despite the fact that numerous hypothesis have been made. A single study of 16 patients proved multivasal damage by a BLASH SCORE analysis of the coronary radiography.…

Malemedicine.medical_specialtytako-tsubo cardiomyopathyCardiomyopathycoronary microcirculation; takotsubo; timi frame countHemodynamicsHealth InformaticsAnterior Descending Coronary ArteryCritical Care and Intensive Care MedicineCoronary AngiographyMicrocirculationTakotsubo CardiomyopathyInternal medicinemedicine.arteryCoronary CirculationMedicineHumansAgedbusiness.industryMicrocirculationmedicine.diseaseStenosisAnesthesiology and Pain Medicinemedicine.anatomical_structureRight coronary arteryCardiologyRadiographic Image Interpretation Computer-AssistedFemalebusinessTIMIBlood Flow VelocityArteryJournal of clinical monitoring and computing
researchProduct

The mutual relationship between heart failure and atrial fibrillation

2020

Atrial fibrillation (AF) and heart failure (HF) are evolving epidemies, together responsible for substantial human suffering and health-care expenditure. The simultaneous co-hexistence of the two conditions is associated with mortality rates higher than those observed in individuals with only one or none of them. Patients with concomitant HF and AF suffer from even worse symptoms and poorer prognosis, yet evidence-based evaluation and management of this group of patients is lacking. In this review, we evaluate the common mechanisms for the development of AF in HF patients and vice versa, focusing on the evidence for potential treatment strategies. Recent data have suggested that these patie…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyAdverse outcomesbusiness.industryMortality ratelcsh:Rheart failurelcsh:MedicineAtrial fibrillationArrhythmia-induced cardiomyopathymedicine.diseaseAtrial fibrillationHeart failure.Risk FactorsHeart failureConcomitantmedicineHumansTreatment strategyBest evidenceCardiology and Cardiovascular MedicineIntensive care medicinebusinessHealthcare system
researchProduct

Serendipity and innovation: history and evolution of transthoracic echocardiography

2017

The history of echocardiography is sprinkled with many interesting episodes and anecdotes showing that devoting your life to the pursuit of one goal is praiseworthy, and that at the same time, a little luck goes a long way. Transthoracic echocardiography (TTE) has led to dramatic improvements in cardiovascular medicine, and is now the most widely used diagnostic cardiac test after electrocardiography (ECG). The present review pays tribute to the pioneering efforts of those who believed in this innovative technology despite mounted skepticism and briefly describes the evolution of TTE from its early days to the most recent developments.

Pulmonary and Respiratory Medicinemedicine.medical_specialtyLuckSerendipitybusiness.industrymedia_common.quotation_subjectmedicineMedical physicsReview ArticlebusinessSkepticismmedia_commonTest (assessment)
researchProduct

Sensitivity, specificity and predictive value of the echocardiography and troponin-T test combination in patients with non-ST elevation acute coronar…

2004

Introduction: Patients with a negative troponin (TnT) result showed 1.4% mortality during a mean follow-up of 9–10 weeks. Mortality was greater in patients with an evidence of ischemic ECG changes and a negative TnT test (1.6–4.4%). Few studies have examined the efficacy of echocardiography (2DE) in patients with chest pain. The purpose of the present study was to determine the clinical utility, sensitivity and specificity of the combination of TnT levels and 2DE in patients presenting with chest pain, ST-depression, T-wave negative and no diagnostic ECG. Methods: 280 consecutive patients with chest pain and presence of ST depression, T-wave inversion, and non-diagnostic ECG, acceptable 2DE…

Malemedicine.medical_specialtyChest PainCoronary DiseaseChest painSensitivity and SpecificityTroponin TPredictive Value of TestsInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingST depressionChi-Square Distributionbiologymedicine.diagnostic_testTroponin Tbusiness.industryST elevationMiddle Agedmusculoskeletal systemTroponinEchocardiographyPredictive value of testsAngiographyAcute Diseasebiology.proteinCardiologyFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessChi-squared distributionFollow-Up StudiesThe international journal of cardiovascular imaging
researchProduct

Prognostic Value of the 6-Min Walk Test After Open-Heart Valve Surgery: EXPERIENCE OF A CARDIOVASCULAR REHABILITATION PROGRAM

2018

PURPOSE: This single-center retrospective analysis aimed to evaluate the prognostic relevance of 6-min walk test (6MWT) in patients admitted to an in-hospital cardiovascular rehabilitation program after open-heart valve surgery. METHODS: One hundred one patients able to perform a 6MWT within the first week of admission (time after surgery: 16 ± 8 d) were included (age 68 ± 11 y; 55% female; median left ventricular ejection fraction 55% [interquartile range: 50-60]; 51% after aortic valve surgery). Study endpoints were cardiovascular death and the combined outcome of cardiovascular death/cardiac hospitalization. Univariate and multivariate analyses were performed to analyze predictive value …

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyHeart Valve DiseasesWalk Test030204 cardiovascular system & hematologyPatient Readmission03 medical and health sciences0302 clinical medicineInterquartile rangePredictive Value of TestsInternal medicineNatriuretic Peptide BrainmedicineHumans030212 general & internal medicineCardiac Surgical ProceduresSurvival rateAgedRetrospective StudiesEjection fractionCardiac Rehabilitationbusiness.industryRehabilitationHazard ratioRetrospective cohort studyStroke VolumeStroke volumeLength of StayMiddle AgedBrain natriuretic peptidePrognosisPeptide FragmentsSurvival RateROC CurvePredictive value of testsArea Under CurveCardiologyFemaleCardiology and Cardiovascular MedicinebusinessFollow-Up Studies
researchProduct

Isolated left ventricular non-compaction: A larger part of submerged iceberg with criteria for diagnosis to the limits of standard

2010

business.industryCompactionMedicineGeotechnical engineeringLeft ventricular non-compaction criteria of diagnosisCardiology and Cardiovascular MedicinebusinessIceberg
researchProduct

Safety and tolerability of abciximab in patients with acute myocardial infarction and failed thrombolysis.

2003

Abstract Aim: The aim of this study was to evaluate glycoprotein IIb/IIIa receptor inhibitor effectiveness in AMI patients with unsuccessful thrombolysis. Methods: Eighty-four patients hospitalised within 4 h of symptom onset were randomised (single blind) into two groups. Regardless of the group, placebo or GP IIb/IIIa inhibitors were administered to patients who did not present with reperfusion signs 30 min after starting thrombolysis and 30–60 min after the end of full thrombolysis in patients with pain recurrence and ST-segment elevation. Reperfusion was assessed by the creatine kinase peak occurring within 12 h, by the observation of rapid ST-segment reduction (50–70% within 1 h) in 12…

Malemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentAbciximabMyocardial InfarctionMyocardial ReperfusionPlatelet Glycoprotein GPIIb-IIIa ComplexPlaceboCoronary AngiographyAnginaElectrocardiographyImmunoglobulin Fab FragmentsInternal medicineFibrinolysisAbciximabmedicineHumansSingle-Blind MethodThrombolytic TherapyMyocardial infarctionTreatment FailureAngioplasty Balloon CoronaryAspirinbusiness.industryAntibodies MonoclonalThrombolysisMiddle Agedmedicine.diseaseTolerabilityResearch DesignAnesthesiaTissue Plasminogen ActivatorCardiologyFemaleSafetyCardiology and Cardiovascular MedicinebusinessPlatelet Aggregation Inhibitorsmedicine.drugInternational journal of cardiology
researchProduct

Effects of Administration of Glycoprotein IIb/IIIa Receptor Antagonists in Patients with Failed Thrombolysis

2001

Aim To evaluate the effectiveness of glycoprotein (GP) IIb/IIIa receptor antagonists in patients with acute myocardial infarction (AMI) who have undergone unsuccessful thrombolysis.

chemistry.chemical_classificationmedicine.medical_specialtybusiness.industrymedicine.medical_treatmentGeneral MedicineThrombolysisTirofibanmedicine.diseaseGastroenterologyPharmacotherapychemistryInternal medicinemedicineAbciximabEptifibatidePharmacology (medical)cardiovascular diseasesMyocardial infarctionGlycoproteinbusinessReceptormedicine.drugClinical Drug Investigation
researchProduct

Safety and efficacy of exercise testing with atropine in patients with recent uncomplicated ST elevation acute myocardial infarction

2012

Background: Exercise testing (ET) remains the most accessible and widely used technique for the detection of coronary artery disease (CAD) and for the assessment of its severity. Failure to reach 85% of maximal predicted heart rate (MPHR) during exercise may render an ET nondiagnostic for ischemia detection in patients with recent uncomplicated ST elevation acute myocardial infarction (STEMI). We sought to investigate the injection of atropine in patients who fail to achieve 85% of age-predicted heart rate during ET, defining its safety and efficacy to raise heart rate to adequate levels as well as to determine its effect on ET interpretation. Methods: Between January 2005 and December 2008…

medicine.medical_specialtyexercise testingmaximal predicted heart ratebusiness.industryST elevationatropineIschemiaRGeneral Medicinemedicine.diseaseSurgeryCoronary artery diseaseAtropinest elevation acute myocardial infarctionInternal medicineHeart ratemedicineCardiologyMedicineIn patientMyocardial infarctionbusinessAdverse effectmedicine.drugOpen Medicine
researchProduct

Safety and feasibility of atropine added in patients with sub-maximal heart rate during exercise myocardial perfusion SPECT.

2006

Failure to reach 80% of maximal predicted heart rate (HR) during exercise may render a myocardial perfusion single photon emission computed tomography (SPECT) study non-diagnostic for ischemia detection. We sought to investigate the injection of atropine in patients who fail to achieve 80% of age-predicted HR during exercise performed for myocardial perfusion SPECT (MPS), defining its safety and efficacy to raise HR to adequate levels as well as its effect on MPS interpretation.Between January 2002 and December 2004, we studied 3,150 consecutive patients (2,253 men and 897 women, mean age 55 +/- 6 years) who were referred to a single office-based nuclear cardiology laboratory for MPS using …

AtropineMalemedicine.medical_specialtyIschemiaMyocardial IschemiaBlood PressureSingle-photon emission computed tomographySeverity of Illness IndexMetabolic equivalentCholinergic AntagonistsOrganophosphorus CompoundsHeart RateInternal medicineSpect imagingCoronary CirculationHeart rateMedicineHumansRadiology Nuclear Medicine and imagingTomography Emission-Computed Single-Photonexercise testingmedicine.diagnostic_testmaximal predicted heart ratebusiness.industrymyocardial perfusion SPECTArrhythmias CardiacOrganotechnetium CompoundsMiddle Agedmedicine.diseaseAtropineRate pressure productResearch DesignCardiologyExercise TestFeasibility StudiesFemaleRadiopharmaceuticalsCardiology and Cardiovascular MedicinebusinessPerfusionmedicine.drugThe international journal of cardiovascular imaging
researchProduct

Relationship between ACE-DD polymorphism and diastolic performance in healthy subjects.

2004

Background—The ACE-D allele has been associated with cardiovascular disease. The study evaluates the relationship between the ACE-ID genotypes and diastolic function in healthy subjects after 6 years of follow-up. Methods—Two hundred and seventy-five healthy volunteers aged 25–55 years had normal physical examination, 12-lead ECG, acceptable echocardiographic windows and echocardiogram at entry. Venous blood was drawn for DNA analysis. Results—Two hundred and forty-two subjects completed 6 years of follow-up. Three genetically distinct groups were obtained: ACE-DD group (n=71, 26F/45M, mean age 48±7 years); ACE-ID (n=115, 39F/76M, mean age 40±7 years); and ACE-II (n=56, 20F/36M, mean age 47…

AdultMalemedicine.medical_specialtyTime FactorsGenotypeDiastolePhysical examinationPeptidyl-Dipeptidase ARisk AssessmentWhite PeopleCohort StudiesSex FactorsPolymorphism (computer science)DiastolePredictive Value of TestsReference ValuesInternal medicinemedicineHumansProspective StudiesProspective cohort studyAllelesProbabilityAnalysis of VariancePolymorphism Geneticmedicine.diagnostic_testbusiness.industryAge FactorsHemodynamicsVenous bloodMiddle AgedEchocardiography DopplerSurgeryPredictive value of testsMultivariate AnalysisCardiologyFemaleAnalysis of varianceCardiology and Cardiovascular MedicinebusinessCohort studyFollow-Up StudiesScandinavian cardiovascular journal : SCJ
researchProduct

Early Effects of Sacubitril/Valsartan on Exercise Tolerance in Patients with Heart Failure with Reduced Ejection Fraction.

2019

Background. Sacubitril/valsartan in heart failure (HF) with reduced ejection fraction (HFrEF) was shown to be superior to enalapril in reducing the risk of death and hospitalization for HF. Our aim was to evaluate the cardiopulmonary effects of sacubitril/valsartan in patients with HFrEF. Methods. We conducted an observational study. Ninety-nine ambulatory patients with HFrEF underwent serial cardiopulmonary exercise tests (CPET) after initiation of sacubitril/valsartan in addition to recommended therapy. Results. At baseline, 37% of patients had New York Heart Association (NYHA) class III. After a median follow-up of 6.2 months (range 3&ndash

medicine.medical_specialtyOxygen pulselcsh:Medicineheart failure030204 cardiovascular system & hematologyArticleSacubitril03 medical and health sciences0302 clinical medicineInternal medicinemedicine030212 general & internal medicineEjection fractionbusiness.industrylcsh:RGeneral Medicinemedicine.diseaseBlood pressureValsartanHeart failuresacubitril/valsartanCardiologyexercise tolerancebusinessAnaerobic exerciseSacubitril Valsartanmedicine.drugcardiopulmonary test
researchProduct

Sacubitril/Valsartan Improves Autonomic Function and Cardiopulmonary Parameters in Patients with Heart Failure with Reduced Ejection Fraction

2020

Background: Heart rate recovery (HRR) is a marker of vagal tone, which is a powerful predictor of mortality in patients with cardiovascular disease. Sacubitril/valsartan (S/V) is a treatment for heart failure with reduced ejection fraction (HFrEF), which impressively impacts cardiovascular outcome. This study aims at evaluating the effects of S/V on HRR and its correlation with cardiopulmonary indexes in HFrEF patients. Methods: Patients with HFrEF admitted to outpatients&rsquo

medicine.medical_specialtyStress testingheart failurelcsh:Medicinecardiopulmonary exercise stress testing030204 cardiovascular system & hematologyArticleSacubitril03 medical and health sciencessacubitril/valsartan heart failure heart rate recovery peak oxygen consumption autonomic function cardiopulmonary exercise stress testing0302 clinical medicineInternal medicineHeart ratemedicine030212 general & internal medicinepeak oxygen consumptionheart rate recoveryEjection fractionbusiness.industrylcsh:RGeneral Medicinemedicine.diseaseValsartansacubitril/valsartanHeart failureBreathingCardiologyautonomic functionbusinesshuman activitiesSacubitril Valsartanmedicine.drugJournal of Clinical Medicine
researchProduct

Six-month echocardiographic study in patients with submassive pulmonary embolism and right ventricle dysfunction: comparison of thrombolysis with hep…

2010

Abstract Introduction The aim of this study was to assess the effect of thrombolysis versus heparin treatment on echocardiographic parameters and clinical outcome, during hospitalization and within the first 180 days after admission, in patients with first episode of submassive pulmonary embolism (SPE) and right ventricle dysfunction (RVD). Methods Consecutive patients (age, 18–75 years) with a first episode of SPE, symptoms onset since no more than 6 hours, normal blood pressure (> 100 mm Hg), echocardiographic evidence of RVD and positive lung spiral computed tomography were double-blind randomized: 1 group received 100 mg of alteplase (10-mg bolus, followed by a 90-mg intravenous infusio…

Adultmedicine.medical_specialtyAdolescentmedicine.drug_classmedicine.medical_treatmentVentricular Dysfunction RightPlacebolaw.inventionYoung AdultRandomized controlled trialDouble-Blind MethodFibrinolytic AgentslawInternal medicineFibrinolysismedicineHumansThrombolytic TherapyAgedFirst episodebusiness.industryHeparinAnticoagulantpulmonary embolism echocardiographyAnticoagulantsGeneral MedicineHeparinThrombolysisMiddle Agedmedicine.diseaseSurgeryPulmonary embolismEchocardiographyTissue Plasminogen ActivatorCardiologyWarfarinbusinessPulmonary Embolismmedicine.drugThe American journal of the medical sciences
researchProduct

rs629301 CELSR2 polymorphism confers a ten-year equivalent risk of critical stenosis assessed by coronary angiography

2021

Abstract Background and aims Novel genetic determinants associated with coronary artery disease (CAD) have been discovered by genome wide association studies. Variants encompassing the CELSR2- PSRC1-SORT1 gene cluster have been associated with CAD. This study is aimed to investigate the rs629301 polymorphism association with the extent of CAD evaluated by coronary angiography (CAG), and to evaluate its associations with an extensive panel of lipid and lipoprotein measurements in a large Italian cohort of 2429 patients. Methods and results The patients were collected by four Intensive Care Units located in Palermo and Verona (Italy). Clinical Records were filed, blood samples were collected,…

MaleApolipoprotein ETime FactorsApolipoprotein BCoronary StenosiEndocrinology Diabetes and MetabolismMedicine (miscellaneous)Genome-wide association study030204 cardiovascular system & hematologyCoronary AngiographyCoronary artery diseaseSeverity of Illness IndexGastroenterologyCoronary artery disease0302 clinical medicineRisk FactorsGenotypeAge FactorNutrition and DieteticsbiologyGene polymorphismAge FactorsSingle NucleotideLipidMiddle AgedCadherinsPrognosisLipidsApolipoproteinPhenotypeItalyFemalelipids (amino acids peptides and proteins)Cardiology and Cardiovascular Medicinemedicine.medical_specialty030209 endocrinology & metabolismRisk AssessmentPolymorphism Single Nucleotide03 medical and health sciencesPredictive Value of TestsIntensive careInternal medicinemedicineHumansGenetic Predisposition to DiseasePolymorphismGenetic Association StudiesAgedbusiness.industryCoronary StenosisBiomarkerOdds ratiomedicine.diseaseSortilinApolipoproteinsbiology.proteinGene polymorphismbusinessBiomarkersNutrition, Metabolism and Cardiovascular Diseases
researchProduct

Nemaline myopathy and heart failure: role of ivabradine; a case report

2015

Background Nemaline myopathy (NM) is a rare congenital myopathy characterized by muscle weakness, hypotonia and the presence in muscle fibers of inclusions known as nemaline bodies and a wide spectrum of clinical phenotypes, ranging from severe forms with neonatal onset to asymptomatic forms. The adult-onset form is heterogeneous in terms of clinical presentation and disease progression. Cardiac involvement occurs in the minority of cases and little is known about medical management in this subgroup of NM patients. We report a rare case of heart failure (HF) in a patient with adult-onset NM in whom ivabradine proved to be able to dramatically improve the clinical picture. Case presentation …

AdultMalemedicine.medical_specialtymedicine.medical_treatmentDilated cardiomyopathyCase ReportMyopathies NemalineElectrocardiographyNemaline myopathyInternal medicinemedicineHumansIvabradineCarvedilolNemaline myopathyHeart FailureEjection fractionbusiness.industryDilated cardiomyopathyCardiovascular AgentsBenzazepinesmedicine.diseaseImplantable cardioverter-defibrillatorCongenital myopathyTreatment OutcomeEchocardiographyHeart failureCardiologybusinessCardiology and Cardiovascular MedicineIvabradinemedicine.drugBMC Cardiovascular Disorders
researchProduct